Characterizing Ligands that have Immunomodulatory potential at the Choroid Plexus in Neurodegenerative Disease

The identification of Gal-3BP and the glycans it carries as Siglec counter-receptors creates new opportunities to explore the potential inflammatory role of glycans in neurodegenerative diseases like AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.089569
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing Ligands that have Immunomodulatory potential at the Choroid Plexus in Neurodegenerative Disease

Katelyn E. Rosenbalm, Michael Tiemeyer, Bhavya Bakshi
Alzheimer s & Dementia
Neuroinflammation and Neurodegeneration Mechanisms
article

Characterizing Ligands that have Immunomodulatory potential at the Choroid Plexus in Neurodegenerative Disease

Katelyn E. Rosenbalm, Michael Tiemeyer, Bhavya Bakshi
article en

Abstract

The identification of Gal-3BP and the glycans it carries as Siglec counter-receptors creates new opportunities to explore the potential inflammatory role of glycans in neurodegenerative diseases like AD.

Alzheimer s & DementiaVol. 20(S1)
University of Georgia (US), Augusta University (US)
Openalex Percentile: Top 72%
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.